Patch testing in occupational dermatology: Practical aspects in relation to the conditions in Germany. [PDF]
Brans R, Skudlik C.
europepmc +1 more source
Frequency of Patch-test Positivity in Patients with Psoriasis: A Prospective Controlled Study
Vivek Malhotra+3 more
openalex +1 more source
CD9‐association with PIP2 areas is regulated by a CD9 salt bridge
The tetraspanin CD9 has an intracellular salt bridge. If CD9 opens, open‐CD9 moves from PIP2‐rich areas to regions populated by its interaction partner EWI‐2. Hence, the state of the salt bridge regulates the distribution of CD9 and by this CD9‐EWI‐2 complex formation.
Yahya Homsi+2 more
wiley +1 more source
Patch Testing in Toilet Seat Dermatitis: A Case Series of Six Patients with Paediatric Atopic Dermatitis. [PDF]
Begum F, Asritha C, Panda M, Agarwal A.
europepmc +1 more source
Analysis of patch testing in patients with hand eczema at Shenzhen from 2016 to 2019. [PDF]
Liang Y, Zhang X, Zhu J, Ali F, Mo H.
europepmc +1 more source
Diagnosing Egg and Milk Hypersensitivity in Children with Atopic Dermatitis using Atopy Patch and Skin Prick Tests [PDF]
Mehtap Yazıcıoğlu+4 more
openalex +1 more source
Two‐way inhibition of PAX5 transcriptional activity by PAX5::CBFA2T3
PAX5::CBFA2T3 (PAX5‐C) is a fusion protein of the B‐cell transcription factor, PAX5, and is found in B‐cell ALL. We propose a putative model of two‐way inhibition of PAX5 transcriptional activity by PAX5‐C. There are two ways of repression by PAX5‐C: DNA‐binding‐dependent way and HDAC‐dependent way, with either being sufficient for the repression. HDAC
Reina Ueno+12 more
wiley +1 more source
Patch testing in children, adults and elderly: Influence of age and sex on sensitization patterns
Stefan Wöhrl+4 more
openalex +1 more source
Testing the Generality of Patch and Landscape-Level Predictors of Tree Squirrel Occurrence at a Regional Scale [PDF]
Robert K. Swihart+3 more
openalex +1 more source
Ro 31‐8220 suppresses bladder cancer progression via enhancing autophagy in vitro and in vivo
The pan‐protein kinase C inhibitor Ro‐31‐8220 demonstrates potent anti‐bladder cancer effects both in vitro and in vivo by suppressing migration/invasion, inducing apoptosis and crucially activating autophagy, where blocking autophagy with chloroquine reduces its cell‐killing efficacy, suggesting its promise as a novel therapeutic candidate requiring ...
Shengjun Fu+12 more
wiley +1 more source